Transatlantic Course of ESR and RSNA (Radiological Society of North America): Advances in Prostate Cancer Imaging and Therapy
TC 927 - Advancements in precision oncology and therapy
Lectures
1
Chairperson's introduction
03:00Patrick Asbach, Berlin / DE
2
Novel multimodality imaging biomarkers
19:00Fiona M. Fennessy, Boston / US
3
Advancements in focal therapies
19:00Katarzyna J. (Kasia) Macura, Baltimore / US
4
Theranostics
--:--James Nagarajah, Nijmegen / NL
5
Panel discussion
10:00Panel discussion
The session will review the role of imaging biomarkers in detection and characterisation of prostate cancer, guidance of personalised treatment planning, prediction and assessment of response to therapy, and detection of disease recurrence. It will review the emerging image-guided focal therapies as methods for personalised treatment of prostate cancer based on risk criteria and optimisation of oncologic and life quality outcomes. It aims to discuss the role of theranostic agents in the treatment of prostate cancer.
3 min
Chairperson's introduction
Patrick Asbach, Berlin / Germany
19 min
Novel multimodality imaging biomarkers
Fiona M. Fennessy, Boston / United States
19 min
Advancements in focal therapies
Katarzyna J. (Kasia) Macura, Baltimore / United States
19 min
Theranostics
James Nagarajah, Nijmegen / Netherlands
10 min
Panel discussion